NCT05754580View on ClinicalTrials.gov

High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

August 29, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Prostatic Cancer
Interventions
RADIATION

High Dose Brachytherapy

This technique involves transient insertion of a stronger (i.e. more active) source (Ir-192) into the prostate, with dose delivery over the course of several minutes followed by immediate removal.

RADIATION

Stereostatic Body Radiation Therapy

ultra-hypofractionation radiation therapy.

Trial Locations (1)

68198

RECRUITING

University of Nebraska Medical Center, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER